I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 5 studies | 21% ± 6% | |
| epithelial cell | 5 studies | 30% ± 13% | |
| natural killer cell | 5 studies | 17% ± 1% | |
| naive B cell | 5 studies | 17% ± 1% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 2% | |
| CD4-positive, alpha-beta T cell | 3 studies | 21% ± 3% | |
| hematopoietic precursor cell | 3 studies | 25% ± 6% | |
| precursor B cell | 3 studies | 21% ± 3% | |
| ciliated cell | 3 studies | 24% ± 2% | |
| CD8-positive, alpha-beta T cell | 3 studies | 22% ± 6% | |
| dendritic cell | 3 studies | 31% ± 4% |
